Pyrimidine derivatives for the prevention of HIV infection

This invention concerns the use of a compound for the manufacture of a medicament for the prevention of HIV infection via sexual intercourse and related intimate contact between partners, wherein the compound is a compound of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaterna...

Full description

Saved in:
Bibliographic Details
Main Authors PAULUS JOANNES LEWI, LUCIEN MARIA HENRICUS KOYMANS, FREDERIK FRANS DESIRE DAEYAERT
Format Patent
LanguageEnglish
Published 30.09.2005
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract This invention concerns the use of a compound for the manufacture of a medicament for the prevention of HIV infection via sexual intercourse and related intimate contact between partners, wherein the compound is a compound of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein the ring containing -a1=a2-a3=a4- and -b1=b2-b3=b4- represents phenyl, pyridyl, pyrimidinyl, pirazinyl, pyridazinyl; n is 0 to 5; m is 1 to 4; R1 is hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6alkyl; C1-6alkyloxycarbonyl; substituted C1-6alkyl, C1-6alkylcarbonyl, C1-6alkyloxycarbonyl, C1-6alkylcarbonyloxy; substituted C1-6alkyloxyC1-6alkylcarbonyl; R2 is hydroxy, halo, optionally substituted C1-6alkyl, C3-7cycloalkyl, optionally substituted C2-6alkenyl, optionally substituted C2-6alkynyl, C1-6alkyloxy, C1-6alkyloxycarbonyl, carboxyl, cyano, nitro, amino, mono- or di(C1-6alkyl)amino, polyhalomethyl, polyhalomethyloxy, polyhalomethylthio, -S( O)pR6, -NH-S( O)pR6, -C( O)R6, -NHC( O)H, -C( O)NHNH2, -NHC( O)R6, -C( NH)R6 or a 5-membered heterocycle; X1 is -NR5-, -NH-NH-, -N N-, -O-, -C( O)-, C1-4alkanediyl, -CHOH-, -S-, -S( O)p-, -X2-C1-4alkanediyl- or -C1-4alkanediyl-X2-; R3 is NHR13; NR13R14; -C( O)-NHR13; -C( O)-NR13R14; -C( O)-R15; -CH N-NH-C( O)-R16; substituted C1-6alkyl; optionally substituted C1-6alkyloxyC1-6alkyl; substituted C2-6alkenyl; substituted C2-6alkynyl; C1-6alkyl substituted with hydroxy and a second substituent; -C( N-O-R8)-C1-4alkyl; R7; or -X3-R7; R4 is halo, hydroxy, C1-6alkyl, C3-7cycloalkyl, C1-6alkyloxy, cyano, nitro, polyhaloC1-6alkyl, polyhaloC1-6alkyloxy, aminocarbonyl, C1-6alkyloxycarbonyl, C1-6alkylcarbonyl, formyl, amino, mono- or di(C1-4alkyl)amino; and pharmaceutical compositions comprising them.
AbstractList This invention concerns the use of a compound for the manufacture of a medicament for the prevention of HIV infection via sexual intercourse and related intimate contact between partners, wherein the compound is a compound of formula a N-oxide, a pharmaceutically acceptable addition salt, a quaternary amine and a stereochemically isomeric form thereof, wherein the ring containing -a1=a2-a3=a4- and -b1=b2-b3=b4- represents phenyl, pyridyl, pyrimidinyl, pirazinyl, pyridazinyl; n is 0 to 5; m is 1 to 4; R1 is hydrogen; aryl; formyl; C1-6alkylcarbonyl; C1-6alkyl; C1-6alkyloxycarbonyl; substituted C1-6alkyl, C1-6alkylcarbonyl, C1-6alkyloxycarbonyl, C1-6alkylcarbonyloxy; substituted C1-6alkyloxyC1-6alkylcarbonyl; R2 is hydroxy, halo, optionally substituted C1-6alkyl, C3-7cycloalkyl, optionally substituted C2-6alkenyl, optionally substituted C2-6alkynyl, C1-6alkyloxy, C1-6alkyloxycarbonyl, carboxyl, cyano, nitro, amino, mono- or di(C1-6alkyl)amino, polyhalomethyl, polyhalomethyloxy, polyhalomethylthio, -S( O)pR6, -NH-S( O)pR6, -C( O)R6, -NHC( O)H, -C( O)NHNH2, -NHC( O)R6, -C( NH)R6 or a 5-membered heterocycle; X1 is -NR5-, -NH-NH-, -N N-, -O-, -C( O)-, C1-4alkanediyl, -CHOH-, -S-, -S( O)p-, -X2-C1-4alkanediyl- or -C1-4alkanediyl-X2-; R3 is NHR13; NR13R14; -C( O)-NHR13; -C( O)-NR13R14; -C( O)-R15; -CH N-NH-C( O)-R16; substituted C1-6alkyl; optionally substituted C1-6alkyloxyC1-6alkyl; substituted C2-6alkenyl; substituted C2-6alkynyl; C1-6alkyl substituted with hydroxy and a second substituent; -C( N-O-R8)-C1-4alkyl; R7; or -X3-R7; R4 is halo, hydroxy, C1-6alkyl, C3-7cycloalkyl, C1-6alkyloxy, cyano, nitro, polyhaloC1-6alkyl, polyhaloC1-6alkyloxy, aminocarbonyl, C1-6alkyloxycarbonyl, C1-6alkylcarbonyl, formyl, amino, mono- or di(C1-4alkyl)amino; and pharmaceutical compositions comprising them.
Author PAULUS JOANNES LEWI
LUCIEN MARIA HENRICUS KOYMANS
FREDERIK FRANS DESIRE DAEYAERT
Author_xml – fullname: PAULUS JOANNES LEWI
– fullname: LUCIEN MARIA HENRICUS KOYMANS
– fullname: FREDERIK FRANS DESIRE DAEYAERT
BookMark eNrjYmDJy89L5WSwCqgsyszNTMnMS1VISS3KLEssySxLLVZIyy9SKMlIVSgoSi1LzSvJzM9TyE9T8PAMU8jMS0tNBgnwMLCmJeYUp_JCaW4GZTfXEGcP3dSC_PjU4oLE5NS81JJ4xwAjAwNTAwNjYzMzRwNj4lQBAEqOMYI
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID AP2005003366A0
GroupedDBID EVB
ID FETCH-epo_espacenet_AP2005003366A03
IEDL.DBID EVB
IngestDate Fri Jul 19 15:22:36 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AP2005003366A03
Notes Application Number: AP20050003366
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050930&DB=EPODOC&CC=AP&NR=2005003366A0
ParticipantIDs epo_espacenet_AP2005003366A0
PublicationCentury 2000
PublicationDate 20050930
PublicationDateYYYYMMDD 2005-09-30
PublicationDate_xml – month: 09
  year: 2005
  text: 20050930
  day: 30
PublicationDecade 2000
PublicationYear 2005
RelatedCompanies JANSSEN PHARMACEUTICA N.V
RelatedCompanies_xml – name: JANSSEN PHARMACEUTICA N.V
Score 2.6335242
Snippet This invention concerns the use of a compound for the manufacture of a medicament for the prevention of HIV infection via sexual intercourse and related...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Pyrimidine derivatives for the prevention of HIV infection
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050930&DB=EPODOC&locale=&CC=AP&NR=2005003366A0
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-LHlIDSt2K6ZP0QinT9oArbisyxt7G2KQjSFlsV_3uvcdU97S0kEJJwl99dcvc7gFuWiMEgSzTVMihV-ap5aEppqlomSkjMMs00mkTh8UQPX_jTYrjowFubCyN5Qr8kOSJqVIL6Xsv7uvx_xPJkbGV1F79iV_EQzGxPab1jhD9GFW9k-9HUm7qK69pOpEyef8coY7ruoIO_0xjSDdO-Px81eSnlJqgEh7Ab4Xx5fQQdkfdg321rr_Vgb7z-8sbmWvuqY7iPvpsiXIg2gqQoOZ-StLsiaHcStONIuaZjKnJSZCR8nJM21Co_gZvAn7mhiotY_u156USbK2an0M2LXJwBsVK60jJNmJkec_SlLDMTQ84TnlARG8w8h_62mS62D1_CgeQmlQERfejW7x_iClG3jq_lYf0AdGWE3w
link.rule.ids 230,309,786,891,25594,76904
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQGlb8V06fohDNnalU7Xrcgceytrm4IgbXFV8b_3Glvd095CAkcS7nL5JXe_A7hlEe92k0iRTZ1SWV2VD00xjWXTQA0JWaIYepko7E0190V9XPaWDXirc2EET-iXIEdEi4rQ3gtxXuf_j1i2iK1c34Wv2JU9OPO-LdXoGN0fo5I97I_8mT2zJMvqD3xp-vw7RhnTtAEC_B0dQWHJtD9aDMu8lHzTqTgHsOujvLQ4hAZP29Cy6tprbdjzqi9vbFbWtz6Ce_-7LMKF3oaTGDXnU5B2rwneOwne40he0TFlKckS4o4XpA61So_hxhnNLVfGSQR_aw4G_uaM2Qk00yzlp0DMmK6UROFGooUqYinTSHhPVSM1ojzUmXEGnW2SzrcPX0PLnXuTYDKePl3AvuApFcERHWgW7x_8Ej1wEV6JjfsB0SuHyg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Pyrimidine+derivatives+for+the+prevention+of+HIV+infection&rft.inventor=PAULUS+JOANNES+LEWI&rft.inventor=LUCIEN+MARIA+HENRICUS+KOYMANS&rft.inventor=FREDERIK+FRANS+DESIRE+DAEYAERT&rft.date=2005-09-30&rft.externalDBID=A0&rft.externalDocID=AP2005003366A0